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Fricke et al. explore the molecular
mechanisms regulating the strength of
inhibitory synaptic transmission and the
GABAAR localization at inhibitory
synapses. Nogo-A/S1PR2 signaling
rapidly strengthens inhibitory synaptic
transmission in the hippocampus, limits
GABAAR diffusion dynamics, and
promotes GABAAR clustering at
synapses in a Ca2+- and calcineurin-
dependent manner.
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Precisely controlling the excitatory and inhibitory
balance is crucial for the stability and information-
processing ability of neuronal networks. However,
the molecular mechanisms maintaining this balance
during ongoing sensory experiences are largely un-
clear. We show that Nogo-A signaling reciprocally
regulates excitatory and inhibitory transmission.
Loss of function for Nogo-A signaling through
S1PR2 rapidly increases GABAAR diffusion, thereby
decreasing their number at synaptic sites and the
amplitude of GABAergic mIPSCs at CA3 hippocam-
pal neurons. This increase in GABAAR diffusion rate
is correlated with an increase in Ca2+ influx and re-
quires the calcineurin-mediated dephosphorylation
of the g2 subunit at serine 327. These results suggest
that Nogo-A signaling rapidly strengthens inhibitory
GABAergic transmission by restricting the diffusion
dynamics of GABAARs. Together with the observa-
tion that Nogo-A signaling regulates excitatory trans-
mission in an oppositemanner, these results suggest
a crucial role for Nogo-A signaling in modulating the
excitation and inhibition balance to restrict synaptic
plasticity.
INTRODUCTION
As inhibitory synaptic transmission plays a crucial role in
shaping the function of the neuronal network, adjustments in
its strength represent a key regulatory mechanism for different
brain processes, such as learning and memory (Barron et al.,
2017; Isaacson and Scanziani, 2011; Maffei, 2011). The
strength of inhibitory GABAergic synapses is defined by the
number of postsynaptic chloride-selective ionotropic type A
GABA receptors (GABAARs) (Kilman et al., 2002; Moss and
Smart, 2001), depending on the rate of their insertion and
removal and their local lateral diffusion (Choquet and Triller,
2013). Thus, the exchange of surface receptors between
synaptic and extrasynaptic sites and their confinement areCe
This is an open access article undamong the most important determinants of the strength of
GABAergic synapses. In hippocampal neurons, fast
GABAergic inhibition is regulated through the control of
GABAAR diffusion in an N-methyl D-aspartic acid receptor
(NMDAR)-dependent and a Ca2+-dependent manner. Sus-
tained Ca2+ influx via NMDARs results in a decrease in
GABAARs at synapses and an increase in their lateral diffu-
sion due to the calcineurin (CaN)-mediated dephosphorylation
of their g2 subunit at serine 327 (Ser327; Bannai et al., 2009;
Luscher et al., 2011; Muir et al., 2010). While extracellular
signaling increasing GABAAR diffusion and thus suppressing
inhibitory transmission have been identified (e.g., brain-
derived neurotrophic factor [BDNF] signaling and increased
neuronal activity [Br€unig et al., 2001; Goodkin et al., 2005]),
little is known about molecules limiting their diffusion and
thereby strengthening inhibition. Addressing this question is
crucial for understanding how the appropriate excitation
and inhibition balance in the brain is maintained, allowing the
tight regulation of plastic processes.
Nogo-A signaling via its receptors NgR1, S1PR2, and PirB is
known to limit neural plasticity in the mature CNS (Schwab
and Strittmatter, 2014). Originally described as a myelin-
derived inhibitor for neurite outgrowth and regeneration (Car-
oni et al., 1988; Chen et al., 2000; Fournier et al., 2001; Grand-
Pré et al., 2002; Schnell and Schwab, 1990), Nogo-A has also
been found to be expressed by subsets of neurons in CNS
areas of high plasticity such as the hippocampus (Huber
et al., 2002; Josephson et al., 2001; Liu et al., 2003; Zagrebel-
sky et al., 2010), where it localizes at synapses (Lee et al.,
2008). Moreover, Nogo-A signaling restricts structural and
functional activity-dependent synaptic plasticity in the intact
adult brain (Akbik et al., 2013; Delekate et al., 2011; Iobbi
et al., 2017; Karlsson et al., 2016; Kellner et al., 2016; Kempf
et al., 2014; Raiker et al., 2010; Syken et al., 2006; Wills
et al., 2012; Zagrebelsky et al., 2010; Zemmar et al., 2014,
2018). Among the molecular mechanisms mediating its ability
to restrict synaptic plasticity, Nogo-A signaling has been
shown to prevent a-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid receptor (AMPAR) insertion at synapses under
basal conditions and upon the induction of long-term potenti-
ation (Kellner et al., 2016). Moreover, the deletion of NgR1 re-
sults in increased adult neural plasticity by facilitatingll Reports 29, 671–684, October 15, 2019 ª 2019 The Authors. 671
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Figure 1. Nogo-A Strengthens Inhibitory Synaptic Transmission via the S1PR2
(A–D) mIPSC recordings in organotypic hippocampal cultures before and after Nogo-A loss-of-function (A, red), Nogo-A gain of function (B, red), S1PR2 inhibition
(C, green), NgR1 loss of function (D, blue), and the respective controls (black). Scale bars, 20 pA vertical and 200 ms horizontal.
(E–L) Normalized mIPSC amplitude and frequency change in percentage upon Nogo-A loss of function (E, ANOVA treatment, p < 0.0001, F1,17 = 45.32; I, ANOVA
treatment, p < 0.05, F1,17 = 6.834, n = 9, red), Nogo-A gain of function (F, ANOVA treatment, p < 0.05, F1,21 = 7.905; J, n = 11, red), S1PR2 inhibition (G, ANOVA
treatment, p < 0.001, F1,18 = 21.72; K, ANOVA treatment, p < 0.05, F1,18 = 6.365, n = 11, green), NgR1 loss of function (H and L, n = 12, blue) and controls (E and I,
n = 10; F and J, n = 12; G and K, n = 9; H and L, n = 13, black).
Values represent means ± SEMs. *p < 0.05, **p < 0.01, ****p < 0.0001.experience-driven delivery of AMPARs at synapses (Jitsuki
et al., 2016). These observations suggest that Nogo-A/NgR1
signaling restricts activity-dependent synaptic plasticity by
regulating the strength of glutamatergic synaptic transmission.
However, no studies so far have addressed a possible role of
the Nogo-A signaling on inhibitory GABAergic transmission.
We report that blocking Nogo-A signaling via the S1PR2 in py-
ramidal hippocampal neurons results in the rapid increase in
GABAAR lateral motility associated with a decrease in their
number at synapses, leading to a decrease in the amplitude
of GABAergic miniature inhibitory postsynaptic currents
(mIPSCs). We also found that the increase in GABAAR motility
upon Nogo-A loss of function is correlated with an increase in
Ca2+ transient amplitude and CaN-mediated dephosphoryla-
tion of the GABAAR g2 subunit at Ser327. Thus, Nogo-A/
S1PR2 signaling rapidly promotes inhibitory GABAergic trans-
mission by modulating the diffusion dynamics of GABAARs
and thereby shifts the excitation and inhibition balance to
restrict synaptic plasticity.672 Cell Reports 29, 671–684, October 15, 2019RESULTS
Nogo-A Strengthens Inhibitory Synaptic Transmission
via the S1PR2
To test whether Nogo-A regulates inhibitory GABAergic synaptic
transmission, mIPSCs of CA3 hippocampal neurons were re-
corded in mouse organotypic slice cultures using whole-cell
voltage clamp. Acute loss of function for Nogo-A, by the applica-
tion of function-blocking antibodies specific for the NiG-D20
inhibitory domain (11C7; Oertle et al., 2003), resulted in a rapid
significant decrease in the normalized mIPSC amplitude starting
5 min after antibody application and reaching a reduction
of 15% compared to controls (Figures 1A and 1E; 5 min: p <
0.05; 10–20 min: p < 0.0001; Figure S1A; Table S1). The normal-
ized mIPSC frequency was significantly reduced up to 10% at
10 and 15 min after Nogo-A blocking antibody application
relative to controls (Figures 1A and 1I; 10 and 15 min: p < 0.05;
Figure S1D; Table S1). Next, a gain-of-function approach

















Ctrl Ab 0 min
Ctrl Ab 10 min
Nogo-A Ab 0 min
Nogo-A Ab 10 min
C











































































Figure 2. Activity-Dependent Localization of Nogo-A at Synapses
(A) Western blot for Nogo-A and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) in synaptosomes from acute hippocampal slices treated (n = 4) or not
treated (n = 4) with 55 mM KCl. The graph shows quantification for the relative
protein abundance.
(B) Western blot (above) for GluR1 and GAPDH in synaptosomes from acute
hippocampal slices with either control antibody (n = 5), 55 mM KCl (n = 5), or
Nogo-A function-blocking antibody (n = 3) and quantification for the relative
protein amount (below).
(C) mEPSC recordings before and 10 min after the application of control or
Nogo-A blocking antibody. Scale bars, 20 pA and 200 ms.
(D and E) mEPSC amplitude (D) and frequency (E) percentage change upon
control (black, n = 10) or Nogo-A blocking antibody (red, n = 11, ANOVA
treatment, p < 0.01, F1,19 = 14.13).
Values represent means ± SEMs. *p < 0.05, ***p < 0.001, ****p < 0.0001.inhibitory peptide (Delekate et al., 2011; Oertle et al., 2003),
was used to verify the specific activity of Nogo-A on inhibitory
synaptic transmission. A short application of the D20 peptide
resulted in a rapid significant increase in mIPSC amplitude up
to 5% at 5 and 10 min after peptide application relative to the
controls (Figures 1B and 1F; 5 min: p < 0.05; Figure S1B; Table
S1) without altering the mIPSC frequency (Figures 1B, 1J, and
S1E; Table S1).
To analyze the downstream signaling of Nogo-A on inhibitory
synaptic transmission, loss-of-function approaches were used
for two of the known Nogo-A receptors, S1PR2 and NgR1, bind-
ing the NiG-D20 and the Nogo-66 inhibitory domains, respec-
tively. Application of the S1PR2 antagonist JTE-013 led to asignificant decrease in mIPSC amplitude beginning at 5 and
peaking at 15 min, with a reduction of 10% relative to the con-
trol (Figures 1C and 1G; 10 min: p < 0.01; 15 min: p < 0.05; Fig-
ure S1C; Table S1), comparable to the one observed upon block-
ing Nogo-A. Moreover, mIPSC frequency was significantly
decreased overall (Figures 1C, 1K, and S1F; Table S1). On the
contrary, when a function-blocking antibody against NgR1 was
used, no alterations could be observed in mIPSC amplitude
(Figures 1D and 1H; Table S1) and frequency (Figures 1D and
1L; Table S1).
These results indicate that Nogo-A signaling rapidly
strengthens inhibitory synaptic transmission via the S1PR2.
Activity-Dependent Localization of Nogo-A at Synapses
Next, we assessed whether the synaptic localization of Nogo-A
is regulated by neuronal activity. To increase neuronal activity,
acute mouse hippocampal slices were incubated with 55 mM
KCl. The amount of Nogo-A in synaptosomes was decreased
by 40% upon stimulation via KCl (Figure 2A; Ctrl: 1.000 ±
0.031; KCl: 0.582 ± 0.062; p < 0.01), showing that the synaptic
localization of Nogo-A is regulated in an activity-dependent
manner. In addition, while KCl slightly increased the AMPAR
subunit GluA1 in synaptosomes, Nogo-A loss of function
resulted in a significant, 2.5-fold increase in GluA1 protein
levels (Figure 2B; Ctrl: 1.000 ± 0.390; KCl: 1.489 ± 0.331;
Nogo-A antibody [Ab]: 2.571 ± 0.378; p < 0.05) confirming the
role of Nogo-A in modulating excitatory synaptic transmission
(Kellner et al., 2016). Acute Nogo-A loss of function led to a
fast, significant increase in the amplitude of miniature excitatory
postsynaptic currents (mEPSCs) peaking 10 min after antibody
application, with an increase of15% relative to the control con-
dition (Figures 2C and 2D; 10 min: p < 0.001; 15 min: p < 0.05;
Table S1). No difference could be observed in mEPSC frequency
(Figures 2C and 2E; Table S1).
The results so far indicate that upon changes in neuronal activ-
ity, Nogo-A signaling at synapses rapidly regulates inhibitory and
excitatory synaptic transmission in a reciprocal manner.
Nogo-A Signaling Promotes GABAAR Clustering at
Synapses via the S1PR2
As the strength of inhibitory synaptic transmission is reflected
in the number of GABAARs at synapses (Kilman et al., 2002;
Nusser et al., 1997), we next tested whether Nogo-A signaling
controls the localization of GABAARs. Live-labeling was used
to visualize surface localization of the GABAAR g2 subunit in
mouse primary hippocampal neurons (Figures 3A–3D). A
10-min loss of function of Nogo-A, by blocking antibody applica-
tion, resulted in a significant decrease in the GABAAR cluster
density of15% (Figure 3E, p < 0.01; Table S2), fluorescence in-
tensity of 30% (Figure 3F, p < 0.001; Table S2), and GABAAR
colocalization with synapsin+ puncta of 20% (Figure 3G, p <
0.001; Table S2). In contrast, a 10-min gain of function for the
Nogo-A NiG-D20 domain, via the application of the soluble
D20 inhibitory peptide, resulted in a significant increase in
GABAAR cluster density of 15% (Figure 3H, p < 0.05; Table
S2) and fluorescence intensity of 30% (Figure 3I, p < 0.01;
Table S2). GABAAR colocalization with synapsin
+ puncta was
slightly increased (Figure 3J; Table S2). Furthermore, a 10-minCell Reports 29, 671–684, October 15, 2019 673













































































































































































































































































Figure 3. Nogo-A Signaling Promotes GABAAR Clustering at Synapses via the S1PR2
(A–D) Live-cell immunolabeling of surface GABAARs followed by immunofluorescence for synapsin in primary hippocampal neurons treated for 10 min with
control (A, left) or Nogo-A blocking antibody (A, right), boiledD20 (B, left) or D20 peptide (B right), DMSO (C, left) or S1PR2 inhibitor JTE-013 (C, right), and control
(D, left) or NgR1 neutralizing antibody (D, right). All of the images underwent deconvolution and were equally increased in brightness and contrast by the same
absolute values. Scale bar, 2 mm.
(E–P) Normalized GABAAR cluster density, fluorescence intensity, and density of colocalized GABAAR and synapsin
+ puncta upon Nogo-A loss of function (E–G,
red, n = 30; Ctrl Ab, gray, n = 30), Nogo-A gain of function (H–J, red, n = 33; boiled D20 peptide, gray, n = 32), S1PR2 loss of function (K–M, green, n = 43; DMSO
Ctrl, gray, n = 51), and NgR1 loss of function (N–P, blue, n = 39; Ctrl Ab, gray, n = 45).
Values represent means ± SEMs. *p < 0.05, **p < 0.01, ***p < 0.001.
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application of the antagonist for the NiG-D20 specific receptor
S1PR2 (JTE-013) led to a significant decrease in GABAAR cluster
density of 10% (Figure 3K, p < 0.05; Table S2), fluorescence
intensity of 20% (Figure 3L, p < 0.01; Table S2), and GABAAR
colocalization with synapsin+ puncta of 15% (Figure 3M,
p < 0.05; Table S2). On the contrary, upon both 10-min NgR1
loss of function and Nogo-66 gain of function via the NgR func-
tion-blocking antibody or the Nogo P4 peptide, no alterations
were observed in GABAAR cluster density (Figures 3N and
S2A; Table S2), fluorescence intensity (Figures 3O and S2B;
Table S2), or GABAAR colocalization with synapsin
+ puncta (Fig-
ures 3P and S2A; Table S2). Under all of the experimental condi-
tions, the density (Figures S2D–S2L; Table S3) and fluorescence
intensity (Figures S2E–S2M; Table S3) of synapsin+ puncta were
not affected.
In summary, these findings show that the Nogo-A NiG-D20
domain signaling via S1PR2 positively regulates the number of
GABAAR clusters and the localization of surface GABAARs at
synapses.
Nogo-A Loss of Function Increases GABAAR Diffusion
Dynamics
Lateral diffusion of GABAARs along the plasma membrane
and their exchange between intra- and extrasynaptic sites
contribute to the inhibitory synaptic transmission by allowing
the alteration of the number of surface GABAARs at synapses.
Quantum dot-based single-particle tracking (QD-SPT; Bannai
et al., 2006) was used to assess whether Nogo-A restricts inhib-
itory transmission by controlling GABAAR diffusion dynamics in
rat primary hippocampal neurons. The application of Nogo-A
blocking antibodies (Figure 4A, red; Nogo-A Ab 0 min: 1.000 ±
0.042; 10 min: 1.255 ± 0.104; p < 0.05) resulted in a significant
increase in the membrane surface explored by QD-GABAAR
diffusion over time compared to controls (Figure 4A, black; Ctrl
Ab 0 min: 1.000 ± 0.058; 10 min: 0.990 ± 0.072). Accordingly,
while the increase in mean square displacement (MSD) of
QD-GABAARs for cells treated with control antibodies did not
change over time, in cells treated with Nogo-A blocking anti-
bodies, it became significantly higher both at synaptic (Figures
S3A and S3B; Table S4) and extrasynaptic sites (Figures S3C
and S3D; Table S4). Moreover, we used the MSD of all of the
trajectories at synaptic and extrasynaptic locations (see Method
Details) to calculate the initial diffusion coefficient (D [mm2/s]) of
labeled GABAARs as a measure of their local mobility. Labeled
GABAARs that had a D < 0.004 mm
2/s were judged immobile.
Nogo-A loss of function led to a significant decrease in the
GABAAR immobile fractions both at synaptic (Figure 4D; Table
S4) and extrasynaptic (Figure 4E; Table S4) sites. At the same
time, the size of the mobile GABAAR fractions (D > 0.004 mm
2/
s) was significantly increased at 5 and 10 min after Nogo-A
blocking antibody application (Figures 4D and 4E), relative to
controls (Figures 4B and 4C). While the application of the
control antibody did not alter GABAAR mobility over time (Fig-
ures 4F and 4G; Table S4), Nogo-A loss of function resulted in
a rapid, significant increase in the GABAAR diffusion coefficient
at synaptic (Figure 4F; Table S4) and extrasynaptic (Figure 4G;
Table S4) sites. The increase in the GABAAR diffusion coefficient
was transient, peaking after 10 min and returning to baseline20min after the application of Nogo-A blocking antibody in com-
parison to control treated cultures (Figures 4F and 4G; Table S4).
Moreover, while themean confinement of QD-GABAARs was not
significantly changed by control antibodies, there was a signifi-
cant increase in confinement upon Nogo-A loss of function (Fig-
ure S3E; Table S4).
These results indicate that Nogo-A rapidly modulates the
GABAAR diffusion dynamics to promote inhibitory synaptic
transmission.
Nogo-AModulates GABAAR Clustering Independently of
Gephyrin
The clustering of GABAARs at synapses has been reported to be
dependent also on the scaffold protein gephyrin confining
GABAARs at inhibitory synapses (Petrini et al., 2014; Tyagarajan
and Fritschy, 2014). To test whether Nogo-A regulates gephyrin
clustering, immunofluorescence for gephyrin was used in pri-
mary hippocampal neurons (Figure 5A). After 10 min of Nogo-A
loss of function, the density (Figure 5B; Table S2) and fluores-
cence intensity (Figure 5C; Table S2) of gephyrin clusters, as
well as their colocalization with synapsin+ puncta, were only
slightly, not significantly, reduced (Figure 5D; Table S2)
compared to the control antibody treatment. No differences
were observed in the density and fluorescence intensity (Fig-
ure S2O; Table S3) of synapsin+ puncta (Figure S2N; Table S3).
These findings indicate that 10 min of Nogo-A loss of function
do not significantly influence gephyrin clustering and suggest a
mechanism by which Nogo-A may directly influence GABAAR
surface dynamics independently of changes in gephyrin
clustering.
Nogo-A Loss of Function Increases Ca2+ Dynamics in
Hippocampal Neurons to Promote GABAAR Diffusion
GABAAR clustering and lateral motility are regulated by Ca
2+
influx into neurons (Bannai et al., 2009, 2015). To assess whether
Nogo-A modulates Ca2+ dynamics, Ca2+ transients were re-
corded over time at dendritic spines in GCaMP5g expressing
mouse primary hippocampal neurons. Nogo-A loss of function
resulted in a significant 2.5-fold increase in the amplitude of
Ca2+ transients already 10 and up to 30 min after antibody
application (Figures 6A, 6B, and S5L; Tables S3 and S6;
20 min: p < 0.05; 30 min: p < 0.01) when compared to controls.
On the contrary, a gain-of-function approach for the NiG-D20
domain of Nogo-A, via the application of the D20 inhibitory pep-
tide, was found to reduce Ca2+ transient amplitude (Figure 6B;
Table S6), compared to the control peptide. While NgR1 loss
of function did not increase the amplitude of Ca2+ transients (Fig-
ures 6B and S5L; Tables S3 and S6), S1PR2 inhibition led to a
significant increase in the amplitude of Ca2+ transients that re-
turned to baseline level 30min after JTE-013 application (Figures
6B and S5L; 10min: p < 0.01; 20min: p < 0.05, Tables S3 and S6)
when compared to controls. No alterations could be observed in
the frequency of Ca2+ transients under all experimental condi-
tions (Figures 6C and S5M; Tables S3 and S6).
The results so far suggest a possible correlation between the
increase in the amplitude of Ca2+ transients upon Nogo-A loss
of function and the increase in GABAAR dynamics. To investigate
the relation between the regulation of Ca2+ signaling andCell Reports 29, 671–684, October 15, 2019 675
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Figure 4. Nogo-A Loss of Function In-
creases GABAAR Diffusion Dynamics
(A) Left: trajectories of GABAAR-QDs recorded for
30 s in 5-min intervals up to 20 min in primary
hippocampal neurons treated with control (black)
or Nogo-A blocking antibody (red). Scale bars,
2 mm. Right: average surface explored by
QD-GABAAR upon control (above, black, n = 14)
and Nogo-A blocking antibody (below, red, n = 14)
at 0 and 10 min.
(B–E) Percentage of fractions of the logarithmic
diffusion coefficient (D, diffusion coefficient) of
GABAAR-QDs upon treatment with control (grays)
or Nogo-A blocking antibody (reds) at synaptic (B
and D) and extrasynaptic sites (C and E) in 5-min
intervals and up to 20 min. Bar graphs show the
percentage of the immobile GABAAR-QD fraction
(D < 0.004 mm2/s) over time (Ctrl Ab, n = 13; Nogo-A
Ab, n = 14).
(F and G) Median diffusion coefficients of
QD-GABAARs with interquartile ranges (IQRs)
upon control (black) or Nogo-A blocking antibody
(red) at synaptic (F) and extrasynaptic sites (G).
Overall, 39,137 trajectories from 14 fields of view
(FOVs, 14 coverslips and 4 preparations) were
analyzed in Nogo-A loss-of-function experiments
(synaptic: 0 min = 2,782, 5 min = 2,664, 10 min =
2,687, 15 min = 2,253, 20 min = 1,848; extra-
synaptic: 0 min = 5,582, 5 min = 5,768, 10 min =
5,703, 15 min = 5,636, 20 min = 4,214). Overall,
35,193 trajectories from 13 FOVs (13 coverslips
and 4 preparations) were analyzed for the control
antibody (synaptic: 0 min = 2,579, 5 min = 2,450,
10 min = 2,471, 15 min = 2,345, 20 min = 1,904;
extrasynaptic: 0 min = 5,181, 5 min = 5,052,
10 min = 4465, 15 min = 4,895, 20 min = 3,851).
Values represent means ± SEMs. *p < 0.05,
**p < 0.01, ***p < 0.001.
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Figure 5. Nogo-A Modulates GABAAR Clustering Independently of
Gephyrin
(A) Immunofluorescence for gephyrin and synapsin in primary hippocampal
neurons treated for 10 min with control (left) or Nogo-A blocking antibody
(right). All of the images underwent deconvolution and were equally increased
in brightness and contrast by the same absolute values. Scale bars, 2 mm.
(B–D) Normalized density of gephyrin clusters (B), fluorescence intensity (C),
and density of gephyrin clusters colocalized with synapsin+ puncta (D, Ctrl Ab,
n = 48; Nogo-A Ab, n = 50) upon treatment with control (gray, n = 63) or Nogo-A
blocking antibody (red, n = 65).
Values represent means ± SEMs.GABAAR diffusion dynamics at a single-cell level, QD-SPT was
used to track GABAARs in rat primary hippocampal neurons
loaded with the Ca2+ indicator Fluo-4 AM to simultaneously
visualize Ca2+ dynamics within the dendrites of the same neuron
(Figure 6D). Again, Nogo-A loss of function resulted in an in-
crease in the diffusion coefficient of GABAARs at synaptic
(Figure S4C; 5 and 10 min: p < 0.01; Table S5) and extrasynaptic
sites (Figure S4D; Table S5) relative to the control conditions
(Figures S4A and S4B; Table S5). Moreover, normalized
GABAAR diffusion dynamics were significantly increased at
synaptic (Figure 6E, +120%; 5 min: p < 0.01; 10 min: p <
0.05; Table S5) and extrasynaptic sites (Figure 6F, +180%;
10 min: p < 0.01; Table S5) after Nogo-A loss of function
compared to controls. This effect derived from a decrease in
less mobile and immobile GABAAR fractions (D < 0.004 mm
2/s)
associated with an increase in the mobile fractions of
GABAARs (D > 0.004 mm
2/s) both at synaptic and extrasy-
naptic sites compared to controls (Figures S4E–S4H; Table
S5). The normalized Fluo-4 fluorescence intensity (F/F0)
increased rapidly after Nogo-A blocking antibody application
(Figure 6G; 5 min: 1.553 ± 0.100; 10 min: 1.768 ± 0.146; 5 min:
p < 0.05; 10 min: p < 0.01) and was significantly different
from the one observed in controls after both 5 and 10 min(Figure 6G; 5 min: 1.114 ± 0.081; 10 min: 1.315 ± 0.090). Also,
when looking at a single-cell level, we found a positive correla-
tion between the peak of Fluo-4 normalized fluorescence inten-
sity and the change in diffusion dynamics in controls (Figure 6H;
RSpearman = 0.429) and significant upon Nogo-A loss of function
(Figure 6H; RSpearman = 0.650; p < 0.05). Finally, live-labeling for
surface GABAAR subunit g2 in mouse primary hippocampal
neurons was combinedwith the application of the Ca2+ chelating
agent EGTA during treatment with Nogo-A blocking antibodies
(Figure 6I). While, as expected, treatment with Nogo-A blocking
antibodies alone significantly decreased GABAAR cluster den-
sity (Figures 6I and 6J; Nogo-A Ab versus Ctrl: p < 0.01; Table
S2), fluorescence intensity (Figure 6K; Nogo-A Ab versus Ctrl:
p < 0.05; Table S2), and GABAAR colocalization with synapsin
+
puncta (Figure 6L; Nogo-A Ab versus Ctrl: p < 0.001; Table
S2), combining the Nogo-A blocking antibodies with EGTA
completely prevented these effects (Figures 6J–6L). Neither the
density (Figures S4I and S4J; Table S3) nor the fluorescence in-
tensity (Figures S4I and S4K; Table S3) of synapsin+ puncta were
affected.
These results suggest that Nogo-A controls Ca2+ dynamics in
hippocampal neurons to limit GABAAR lateral movement, and
thereby their localization at synapses.
Nogo-A Controls GABAAR Localization at Synapses via
the Ca2+-Dependent Phosphatase Calcineurin
GABAAR clustering and diffusion dynamics are regulated via
changes in the activation of the Ca2+-dependent protein phos-
phatase 3 calcineurin (CaN; Muir et al., 2010; Nakamura et al.,
2015; Niwa et al., 2012). We asked whether the ability of Nogo-
A signaling to promote Ca2+ dynamics may be involved in regu-
lating GABAAR clustering at synapses by altering CaN activity.
Live-labeling for surface GABAAR subunit g2 was used in mouse
primary hippocampal neurons treated with control or Nogo-A
function-blocking antibodies with or without the specific CaN
inhibitor cyclosporin A (Cys A; Figure 7A). A 10-min Nogo-A
loss of function significantly decreased GABAAR cluster density
(Figure 7B, p < 0.01; Table S2), fluorescence intensity (Figure 7C,
p < 0.05; Table S2) and their colocalization with synapsin+
puncta (Figure 7D, p < 0.05; Table S2). The co-application of
Cys A and the Nogo-A blocking antibody completely prevented
the decrease in GABAAR cluster density (Figure 7B; Table S2),
fluorescence intensity (Figure 7C; Table S2), and colocalization
with synapsin+ puncta (Figure 7D; Table S2).
CaN regulates GABAAR clustering and lateral diffusion by de-
phosphorylating GABAAR g2 subunit at Ser327 (Muir et al.,
2010). Thus, we hypothesized that Nogo-A signaling regulates
GABAAR g2 subunit phosphorylation at Ser327, thereby control-
ling synaptic localization of GABAARs. Phosphorylation at
Ser327 of the GABAARs g2 subunit was immunocytochemically
detected in mouse primary hippocampal neurons treated with
Nogo-A blocking or control antibodies (Figure 7E). Nogo-A loss
of function for 10 min resulted in a decrease in the GABAAR g2
pSer327 density (Figure 7F; p < 0.05, Table S2), fluorescence in-
tensity (Figure 7G; p < 0.001, Table S2), and overlap between
pSer327+ and GABAAR
+ puncta (Figure 7H; p < 0.05, Table
S2). However, co-application of the CaN inhibitor Cys A with
the Nogo-A blocking antibody completely prevented theCell Reports 29, 671–684, October 15, 2019 677
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Figure 6. Nogo-A Loss of Function Increases Ca2+ Dynamics in Hippocampal Neurons to Promote GABAAR Diffusion
(A) Images and relative fluorescence intensity traces for GCaMP5g expressing primary hippocampal neurons before (0 min, above) and after (20 min, below)
application of Nogo-A blocking antibody.
(B and C) Normalized Ca2+ transient amplitude (B) and frequency (C) over time for dendritic spines of primary hippocampal neurons treated with, from left, control
(black, n = 42), Nogo-A blocking (red, ANOVA treatment, p < 0.01, F1,62 = 8.014, n = 37), NgR1 blocking antibody (blue, n = 11), control DMSO (black, n = 15),
S1PR2 antagonist JTE-013 (green, ANOVA treatment, p < 0.01, F1,28 = 8.490, n = 15), boiledD20 peptide (black, n = 6), orD20 peptide (orange, ANOVA treatment,
p = 0.058, F1,16 = 4.318, n = 8).
(D) GABAAR-QD trajectories over 30 s and Fluo-4 fluorescence in primary hippocampal neurons. Scale bar, 5 mm.
(E and F) Normalized percentage change over time for the diffusion coefficient median upon control (black, n = 12) and Nogo-A blocking antibody (red, n = 12) at
synaptic (E, ANOVA treatment, p < 0.001, F1,24 = 16.25) and extrasynaptic sites (F, ANOVA treatment, p < 0.01, F1,24 = 8.006).
(G) Normalized Fluo-4 fluorescence intensity change over time (F/F0) for control (black, n = 12) and Nogo-A blocking antibody (red, ANOVA treatment, p < 0.001,
F1,24 = 9.804, n = 12).
(H) Correlation between the peak value for the Fluo-4 fluorescence intensity change (F/F0) and the diffusion coefficient for control (black dots, n = 12) and Nogo-A
blocking antibody (red dots, n = 12).
(I) Hippocampal primary neurons treatedwith control or Nogo-A blocking antibody with or without EGTA and stained for surfaceGABAARs and synapsin. All of the
images underwent deconvolution and were equally increased in brightness and contrast by the same absolute values. Scale bars, 2 mm.
(J–L) NormalizedGABAAR cluster density (J), fluorescence intensity (K), and colocalization of GABAAR and synapsin
+ puncta (L) uponNogo-A loss of function with
(Ctrl Ab, n = 32; Nogo-A Ab, n = 33) or without EGTA (Ctrl Ab, n = 30; Nogo-A Ab, n = 29).
Values represent means ± SEMs. *p < 0.05, **p < 0.01, ***p < 0.001.decrease in all of the above parameters for GABAAR g2 (Figures
7F–7H; Table S2). GABAAR g2 puncta density (Figure S5G; Table
S2) and fluorescence intensity (Figure S5H; Table S2) were not
affected, indicating that the treatment did not affect the total
number of GABAARs. Finally, to confirm the requirement for
the GABAAR g2 dephosphorylation at pSer327 for the regulation
of GABAAR localization by Nogo-A loss of function, live-labeling
of surface GABAAR subunit a2 was used for hippocampal
primary neurons transfected with an myc-tagged g2 GABAAR678 Cell Reports 29, 671–684, October 15, 2019subunit, either with its S327 phosphorylation site intact
(g2-myc) or with S327 mutated to alanine (g2S327A-myc; Muir
et al., 2010). While neurons transfected with g2-myc showed a
significant reduction in GABAAR a2 cluster intensity upon a
10-min Nogo-A loss of function (Figure 7K; p < 0.05, Table S2),
this was completely prevented by g2S327A-myc expression
(Figure 7K; Table S2). No changes could be observed in
cluster density (Figure 7J; Table S2) and colocalization between
GABAAR a2 and synapsin
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Synapsin+ puncta density and fluorescence intensity (Figures S4
and S5; Table S3) were unchanged in all of the experimental
conditions.
These findings indicate that a loss of function for Nogo-A
signaling rapidly regulates GABAAR localization at synapses by
modulating the CaN activation status, resulting in the dephos-
phorylation of GABAAR subunit g2 at pSer327.
DISCUSSION
In this study, we show that Nogo-A signaling restricts inhibitory
synaptic transmission by controlling the synaptic accumulation
and the diffusion dynamics of GABAARs in primary hippocampal
neurons. While a gain of function for the Nogo-A NiG-D20
domain increases the mIPSC amplitude and the intensity of
synaptic GABAAR clusters, blocking the function of this Nogo-
A domain or its receptor S1PR2 results in the rapid decrease in
mIPSC amplitude and in the reduced size of synaptic GABAAR
clusters. These effects are due to an increase in the lateral
diffusion of GABAARs at both synaptic and extrasynaptic sites
as seen using SPT of GABAARs labeled with quantum dots.
The regulation of GABAAR diffusion dynamics by Nogo-A
signaling occurs at a timescale of minutes and depends upon
an increase in intracellular Ca2+ and the activation of the phos-
phatase CaN.
The diffusion properties of surface GABAARs in hippocampal
neurons have been previously shown to depend on the activ-
ity-dependent increase in the intracellular Ca2+ concentration
[Ca2+]i (Bannai et al., 2009). Here, the Fluo-4 imaging shows a
strong increase in [Ca2+]i following Nogo-A loss of function as
well as a positive correlation between the increase in [Ca2+]i
and in GABAAR lateral diffusion. Moreover, by co-application
of EGTA, we show that the increase in Ca2+ dynamics upon
Nogo-A loss of function is required for its effect on GABAAR
localization at synapses. Our results also confirm the previously
observed increase in excitatory synaptic transmission (Berry
et al., 2018; Kellner et al., 2016; Figure 2) and a significant in-
crease in the amount of AMPARs at synapses upon Nogo-A
function-blocking. While an increase in [Ca2+]i is associated
with an increase in the diffusion coefficient of GABAARs (BannaiFigure 7. Nogo-A Controls GABAAR Localization at Synapses via the C
(A) Immunofluorescence for surface GABAARs and synapsin in primary hippocamp
(left) or with (right) the CaN inhibitor cyclosporin A (Cys A).
(B–D) Normalized GABAAR cluster density (B), fluorescence intensity (C), and co
without (Ctrl Ab, n = 26; Nogo-A Ab, n = 28) or with (Ctrl Ab, n = 31; Nogo-A Ab,
(E) Immunofluorescence for pSer327 g2, GABAAR g2, and synapsin in hippocamp
without (left) or with (right) the CaN inhibitor Cys A.
(F–H) Normalized pSer327 g2 cluster density (F), fluorescence intensity (G), and
Nogo-A loss of function without (Ctrl Ab, n = 22; Nogo-A Ab, n = 22) or with (Ctrl
(I) Images of hippocampal primary neurons expressing themyc-taggedGABAAR g
to alanine (g2S327A-myc, right), stained for the surface GABAAR a2 subunit and s
(J–L) Normalized a2 cluster density (J), fluorescence intensity (K), and colocalizatio
(g2-myc Ctrl Ab, n = 32 and Nogo-A Ab, n = 32; g2S327A-myc Ctrl Ab, n = 33 and N
increased in brightness and contrast by the same absolute values. Scale bars, 2
(M) Scheme summarizing our findings. Under Nogo-A signaling conditions, the
synapses (left). Upon Nogo-A loss of function, the influx of Ca2+ activates CaN, res
lateral diffusion.
Values represent means ± SEMs. *p < 0.05, **p < 0.01, ***p < 0.001.
680 Cell Reports 29, 671–684, October 15, 2019et al., 2009), high [Ca2+]i results in a decrease in the movement of
AMPARs due to their increased confinement (Borgdorff and
Choquet, 2002; Heine et al., 2008). The ability of Nogo-A to recip-
rocally regulate GABAAR and AMPAR localization at synapses
by modulating [Ca2+]i may represent a mechanism that rapidly
tunes excitatory and inhibitory transmission in an activity-depen-
dent manner. Our observation that the localization of Nogo-A at
synapses is rapidly reduced upon an increase in neuronal activity
supports this hypothesis.
The strength of inhibitory synaptic transmission is determined
by the number of GABAARs at synaptic sites, depending on their
confinement, the rate of their insertion and removal, and their
local lateral diffusion in the membrane (Choquet and Triller,
2013). In this study, we show that Nogo-A loss of function results
in an increased lateral diffusion of GABAARs both synaptically
and extrasynaptically. This is due to an increase in the mobility
of GABAARs and a decrease in the fraction of immobile
GABAARs, suggesting a general increase in the exchange of
receptors between synaptic and extrasynaptic sites. The
confinement of receptors at synapses is regulated by different
mechanisms acting on either the localization of scaffold mole-
cules or the strength of the receptor-scaffold interactions (Cho-
quet and Triller, 2003; Triller and Choquet, 2005) or by a combi-
nation of the two (Bannai et al., 2009). While in previous studies
the increase in lateral diffusion of GABAARs has been shown to
be followed by a delayed loss of their scaffold protein gephyrin
(Bannai et al., 2009; Papadopoulos et al., 2007), we have
observed different effects. Within the time we analyzed, no
decrease in the density or intensity of gephyrin clusters
occurred, in spite of the significant reduction in number and
size of GABAAR clusters. Previous studies have shown that the
gephyrin clustering at synapses depends on the integrity of
F-actin and of microtubules (Charrier et al., 2006; Kirsch and
Betz, 1995). Nogo-A loss of function has been shown to increase
F-actin stability and to promote (Iobbi et al., 2017; Kellner et al.,
2016) microtubule disassembly via a rho-kinase-dependent
mechanism (Mimura et al., 2006), possibly preventing the loss
of gephyrin. Previous observations indicate that gephyrin
dispersal is not required for GABAAR declustering (Niwa et al.,
2012). Our results suggest that the increase in GABAAR diffusiona2+-Dependent Phosphatase Calcineurin
al neurons treated for 10min with control or Nogo-A blocking antibody without
localization with synapsin+ puncta (D) upon control or Nogo-A loss of function
n = 34) Cys A.
al primary neurons treated for 10min with control or Nogo-A blocking antibody
density of colocalized pSer327 g2 and synapsin+ puncta (H) upon control or
Ab, n = 24; Nogo-A Ab, n = 24) Cys A.
2 subunit with the pSer327 phosphorylation site intact (g2-myc, left) or mutated
ynapsin and treated for 10 min with control or Nogo-A blocking antibody.
n between a2 and synapsin+ puncta (L) upon control or Nogo-A loss of function
ogo-A Ab, n = 32). All of the images underwent deconvolution and were equally
mm.
phosphorylation of GABAARs at pSer327 keeps them clustered at inhibitory
ulting in the dephosphorylation of GABAARs at pSer327 and an increase in their
follows a change in the binding of GABAARs to the scaffold
proteins rather than a declustering of gephyrin. A major mecha-
nism regulating the trafficking of GABAARs is the direct phos-
phorylation and dephosphorylation of residues within the intra-
cellular loop (Kittler and Moss, 2003; Vithlani et al., 2011). Mice
in which the phosphorylation of the g2 subunits of GABAARs is
prevented show an accumulation of GABAARs at inhibitory syn-
apses in CA3 neurons due to their aberrant trafficking (Tretter
et al., 2009). In particular, a crucial role in regulating GABAAR
lateral mobility is exerted by the phosphorylation status of
Ser327 of the g2 subunit, a known substrate for the Ca2+-depen-
dent phosphatase CaN (Muir et al., 2010; Wang et al., 2003). A
function of CaN downstream of Nogo-A signaling in regulating
the synaptic localization of GABAARs is supported by our obser-
vation that the effects of a loss-of-function approach for Nogo-A
are completely prevented by the co-application of Cys A, a
specific CaN inhibitor. Moreover, we observe that the phosphor-
ylation at Ser327 of the g2 subunit is reduced upon blocking
Nogo-A, but not when the activation of CaN is prevented by
co-application of Cys A. CaN has been identified as a major
regulator of bidirectional plasticity due to its ability to regulate
both inhibitory and excitatory synaptic transmission. While
CaN also dephosphorylates AMPARs at Ser845, thereby pro-
moting their internalization (Kessels and Malinow, 2009; Man
et al., 2007), our results show a strengthening rather than a
weakening of excitatory synaptic transmission and an increase
in AMPARs at synapses. However, the trafficking of surface
AMPARs also depends on the stability of F-actin within spines.
It is conceivable that the increased F-actin stability upon
Nogo-A loss of function (Kellner et al., 2016) may promote the
accumulation of AMPARs at synaptic sites observed in our
study. Furthermore, the studies showing a negative effect of
CaN activity on the strength of excitatory synapses and long-
term potentiation (LTP) rely on its genetic manipulation (Malleret
et al., 2001; Sanderson et al., 2018) and therefore address much
longer time points of CaN loss of function than in our experiment
upon its acute inhibition via Cys A. Timing and the cellular local-
ization and activation kinetics of CaN may influence the net
outcome of its loss of function (Li et al., 2012).
We show that acute loss of function for the Nogo-A specific
NiG-D20 inhibitory domain increases Ca2+ influx and
strengthens excitatory synaptic transmission while reducing
inhibitory synaptic transmission. These observations are consis-
tent with recent studies showing that the blockade of Nogo-A
increases functional and structural plasticity in the hippocampus
and cerebral cortex (Akbik et al., 2013; Delekate et al., 2011; Jit-
suki et al., 2016; Kellner et al., 2016; Lee et al., 2008; Raiker et al.,
2010; Zemmar et al., 2014) and further support novel roles for
this protein beyond its function as an inhibitor of neuronal regen-
eration upon injury (Schwab and Strittmatter, 2014). Our results
in particular identify the ability of Nogo-A to modulate inhibitory
synaptic transmission as a possible mechanism that mediates
its role as a molecular brake acting to restrict synaptic plasticity.
While a decrease in the ratio between excitation and inhibition
(E/I balance) coincides with the closure of the critical period
(Morales et al., 2002) and restricts plasticity to the adult levels
(Levelt and H€ubener, 2012; Morishita and Hensch, 2008), disin-
hibition initiates plasticity in the visual cortex (Kuhlman et al.,2013). Nogo-A/B and NgR1 knockout mice retain levels of
plasticity that are typical of the critical period also as adults
(McGee et al., 2005) and show lower levels of cortical inhibi-
tion (Stephany et al., 2014), suggesting that signaling via NgR1
limits disinhibition to drive the closure of the critical period
in the visual cortex. In our study, while blocking the S1PR2
(specific receptor for the Nogo-A NiG-D20 domain) reproduced
the increase in Ca2+ influx and the reduction in inhibitory syn-
aptic transmission, a loss of function for NgR1 did not influence
these parameters. However, NgR1 loss of function was shown
to increase LTP (Delekate et al., 2011; Zemmar et al., 2014)
and to restrict the insertion of AMPARs at synapses upon
learning (Jitsuki et al., 2016). Finally, the lower inhibition levels
in the visual cortex of NgR1 knockout mice have been shown
to derive from a reduction in the excitatory drive onto parvalbu-
min+ interneurons (Stephany et al., 2014), suggesting that
NgR1 signaling may specifically affect excitatory and not inhibi-
tory synaptic transmission. However, the results of experiments
in which GABAergic transmission was blocked during neutraliza-
tion of the Nogo-A NiG-D20 domain indicate that the increase in
LTP following a Nogo-A loss of function may be due to the sup-
pression of inhibition (Delekate et al., 2011). During the onset of
LTP, the concomitant decrease in IPSPs is required to increase
the ability of EPSPs to generate a spike (Lu et al., 2000; Wang
and Stelzer, 1996). In our study, the reduction in the amplitude
of mIPSCs after Nogo-A neutralization shortly precedes the in-
crease in mEPSC amplitude. Therefore, our results suggest
that, while signaling of Nogo-A or other ligands via NgR1 regulate
selectively excitatory synaptic transmission, Nogo-A signaling
via its S1PR2 exerts a Nogo-A-specific effect in controlling inhib-
itory synaptic transmission, by regulating GABAAR localization at
inhibitory synapses, and their diffusion dynamics and excitatory
synaptic transmission, by regulating AMPAR surface insertion.
Our observation of an increase in amplitude but not in frequency
of mEPSCs upon Nogo-A loss of function and the lack of loss in
synapsin under this condition supports a previously suggested
postsynaptic action of Nogo-A (Delekate et al., 2011). Although
our current data do not support it, an involvement of the PirB re-
ceptor in modulating GABAAR dynamics can at this point not be
excluded.
To consider Nogo-A as a main player in orchestrating the con-
trol of synaptic strength and in modulating the excitation-inhibi-
tion balance, its synaptic localization or the one of its receptors
must be regulated by neuronal activity. We show that the surface
expression of Nogo-A at synapses is reduced upon an increase
in neuronal activity. While this observation leaves open the pos-
sibility that the localization of the Nogo-A receptors is alsomodu-
lated by neuronal activity, it furthers our understanding about
how Nogo-A can respond to changes in neuronal activity by
rapidly regulating synaptic plasticity.
While the correct balance between excitation and inhibition
is crucial for normal brain function, the molecular mechanisms
underlying it are still largely unclear. Only recently has cad-
herin-10 been described as a reciprocal modulator of excitatory
and inhibitory synaptic transmission by promoting excitation
while suppressing inhibition (Smith et al., 2017). Moreover, while
molecules that negatively modulate inhibition have been already
described, for example, BDNF (Br€unig et al., 2001; GoodkinCell Reports 29, 671–684, October 15, 2019 681
et al., 2005), less is known aboutmolecules promoting it. We now
identify Nogo-A as a reciprocal modulator of excitation and inhi-
bition acting to simultaneously promote inhibitory and suppress
excitatory synaptic transmission in the hippocampus. The
signaling of Nogo-A, which is localized in an activity-dependent
manner at synaptic sites in the hippocampus, rapidly increases
GABAergic transmission by regulating the diffusion dynamics
of GABAARs in a [Ca
2+]i- and CaN-dependent manner. Along
with the observation that Nogo-A signaling suppresses excit-
atory synaptic transmission, our results support a role for
Nogo-A in fine-tuning neuronal plasticity by controlling the ratio
between excitation and inhibition. Understanding this contrib-
utes to the knowledge of the basic physiological homeostatic
molecular mechanisms involved in controlling neuronal plas-
ticity, and thereby learning and memory processes.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
In this study male and female C57BL/6J OlaHsd mice and Wistar rats were used. All procedures concerning animals were approved
by the animal welfare representative of the TU Braunschweig and the LAVES (Oldenburg, Germany, Az. x4 (02.05) TSchB TU BS).
Primary mouse hippocampal culture
Primary hippocampal cultures were prepared from C57BL/6 mice at embryonic day 18 as previously described (Kellner et al., 2014;
Zagrebelsky et al., 2018). Themouse embryoswere removed from the uterus and decapitated. Under sterile conditions the upper half
of the brain was dissected and kept in ice cold Gey’s balanced salt solution (GBSS) supplemented with glucose and adjusted to pH
7.2. The dissociation of the hippocampus was achieved by incubation with Trypsin / EDTA at 37C for 30 min and by subsequent
mechanical dissociation. The cells were plated at a density of 3.5x104 (live-cell labeling and immunofluorescence) or 7x104 (Ca2+ im-
aging with GCaMP5) cells per well on poly-L-lysine coated coverslips. The cells were kept in Neurobasal medium (NB-, #21103049,
Thermo Fisher) supplemented with 2% B27, 11% N2 and 0.5 mM Glutamax (NB
+) at 37C, 5% CO2 and 99% humidity.
Primary rat hippocampal culture
Primary rat hippocampal cultures were prepared from embryonic Wistar rats at embryonic day 18 as described previously (Banker,
1980; Frischknecht et al., 2008). In brief, after dissociation with trypsin the cell suspension was plated onto poly-L-lysine- (Sigma)
coated 18mmglass coverslips (Menzel-Glaeser, Braunschweig, Germany) at a density of 30,000 cells per coverslip. After incubation
in Dulbecco’s Modified Eagle Medium (DMEM) plus fetal bovine serum at 37C for 1-2 h, five coverslips were placed into a 35 mme2 Cell Reports 29, 671–684.e1–e6, October 15, 2019
Petri dish containing a 70%–80% confluent monolayer of astrocytes in neurobasal medium supplemented with B27 and 5mM gluta-
mine. The cultures were maintained in a humidified incubator at 37Cwith an atmosphere of 95% air and 5%CO2. At 3 DIV AraC was
added to the cells to a final concentration of 1.4 mM.
Mouse organotypic hippocampal slice culture
Organotypic hippocampal cultures were prepared from postnatal day 5 (P5) C57BL/6 mice of either sex as described previously
(Michaelsen-Preusse et al., 2014; Stoppini et al., 1991). The mice were decapitated and the hippocampi were dissected in ice-
cold sterile Gey’s balanced salt solution (GBSS). Transversal slices were cut using a tissue chopper (McIlwain) at a thickness of
400 mm. The slices were placed on Millicells CM membrane inserts (Millipore) and cultivated at 37C, 5% CO2 and 99% humidity
in a medium containing 50% BME (Eagle, with Hanks salts without glutamine), 25% Hank’s Buffered Salt Solution (HBSS), 1%
glucose, 25% donor equine serum (HyClone), and 0.5% L-glutamine. A mixture of antimitotic drugs (cytosine arabinoside, uridine,
and fluorodeoxyuridine; 106 to 107 M each) was applied for 24 h 3 days after preparation.
Acute mouse hippocampal slices
Acute hippocampal slices were prepared from 6-8 weeks old C57BL/6 mice. The mice were euthanized with CO2, decapitated and
the brain was dissected and incubated for 3 min in 4C carbogenated (95%O2, 5%CO2) artificial cerebrospinal fluid (ACSF) contain-
ing 125mMNaCl, 2.5 mMKCl, 1.25mMNaH2PO4, 2mMMgCl2, 26mMNaHCO3, 2mMCaCl2, and 25mMglucose. The hippocampi
were dissected and 400 mm thick transversal slices were cut with a Tissue Slicer (Stoelting). The slices were maintained at room
temperature for at least 90 min in a submerged storage chamber with carbogenated ACSF before treatment.
METHOD DETAILS
Antibody and peptide treatment
The loss-of-function for the Nogo-A signaling was achieved by application of: a monoclonal Nogo-A specific, function-blocking
antibody against an 18-aa peptide within the NiG-D20 domain, the most inhibitory region of Nogo-A (mouse IgG1 11C7; 5mg / mL
gift from Martin Schwab, ETH and University of Zurich; Liebscher et al., 2005; Oertle et al., 2003); an antagonist of the sphingo-
sine-1-phosphate receptor 2 (S1PR2; 5 mM JTE-013; Tocris) or a function-blocking antibody against the Nogo receptor
NgR1 (5 mg/ml affinity-purified goat IgG anti-Nogo receptor; R&D Systems). A control mouse IgG1 (mouse IgG1 anti-BrdU, FG12,
5mg /mL, gift fromMartin Schwab, ETH and University of Zurich) antibody was used as control for Nogo-A and NgR1 loss-of-function
experiments. The gain-of-function for the Nogo-A NiG-D20 and Nogo-66 domains were obtained by application of the D20 (300 nM;
Oertle et al., 2003, gift from Martin Schwab, ETH and University of Zurich) and P4 soluble peptides (4 mM; Alpha Diagnostic Interna-
tional). The boiled D20 and P4 peptides were used as controls in all experiments except for patch clamp recording, where PBS was
used. For antibodies and peptides solved in DMSO, PBS or H20 an equal amount of solvent was used as control. The treatments were
applied as follows: 1) for patch clamp recording, single particle tracking and calcium imaging experiments: the application started
right after the first time point acquisition and lasted until the end of the experiment. The different agents were diluted in ACSF (con-
taining in mM 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 MgCl2*6H2O, 2 CaCl2*2H2O, 25 D-glucose*H2O; pH 7.4) saturated
with carbogen and supplemented with 1 mM tetrodotoxin, 10 mM bicuculline (mEPSCs), 20 mM CNQX (mIPSCs) for patch clamp, in
extracellular solution (145mMNaCl, 10mMGlucose, 10mMHEPES, 5mMKCl, 2mMCaCl2, 2mMMgCl2) for single particle tracking
and in Hank’s buffered salt solution (HBSS) for calcium imaging; 2) for live cell labeling the treatments were performed for 10min right
before fixation in a humidified incubator at 37Cwith an atmosphere of 95%air and 5%CO2. The agents were diluted in NB
medium;
3) for the synapstosomes preparation for 10 min in ACSF (containing in mM 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2
MgCl2*6H2O, 2 CaCl2*2H2O, 25 D-glucose*H2O; pH 7.4) saturated with carbogen.
Patch clamp electrophysiology
Somatic whole-cell recording was performed on visually identified pyramidal neurons in the CA3b area in 21 to 25 DIV organotypic
mouse hippocampal slice cultures. The slices were transferred to an open imaging chamber at 32C, continuously perfused (1 mL/
min) with ACSF (containing in mM 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 MgCl2*6H2O, 2 CaCl2*2H2O, 25 D-glucose*H2O;
pH 7.4) saturated with carbogen and supplemented with 1 mM tetrodotoxin, 10 mM bicuculline (mEPSCs), 20 mM CNQX (mIPSCs).
The antibodies and peptides were diluted in ACSF at the stated concentrations (see antibody and peptide treatment section). The
slices were let to adapt for 20 min before starting the recording. Glass pipette electrodes (resistance: 4.0-6.5 MU) were pulled
with a PC-10 vertical micropipette puller (Narishige) from borosilicate capillaries (1.5 mm). The pipette internal solution contained
(in mM) 70 K-gluconate, 70 KCl, 10 HEPES, 0.5 EGTA, 4 MgATP, 0.4 NaGTP and 4 Na2phosphocreatine (pH 7.3). Patching was per-
formed under a Zeiss (Axioskop 2 FS Plus) microscope using a 40X water-immersion objective (0.8 NA). Cells were voltage-clamped
at 70 mV and mIPSCs and mEPSCs were recorded every 5 min for 120 s up to 30 min after starting antibody application. Input
resistance (Rin) and series resistance (Rs) were monitored throughout the recordings and only stable cells (< 20% change in Rin
and Rs) with Rin > 100 MU and Rs < 25 MU were included in the analysis. Signals were amplified using a Multiclamp 700B amplifier
(Molecular Devices) and digitized with a Digidata 1322A digitizer (Molecular Devices). Data analysis was performedwithMini AnalysisCell Reports 29, 671–684.e1–e6, October 15, 2019 e3
software (Justin Lee). The data are presented as mean ± standard error of the mean (SEM). Statistical analysis was performed in
Prism (GraphPad) using a Two-Way ANOVA with Sidak’s multiple comparison post hoc test.
Transfection of primary hippocampal neurons
At 21 DIV, cultured mouse hippocampal neurons were transfected with 0.8 mg of the DNA expression plasmid for GABAAR g2-myc or
GABAAR g2
S327A-myc under a CMV promoter (Muir et al., 2010) using Lipofectamine 2000 transfection reagent (ThermoFisher Sci-
entific). The transfection mix was prepared in NB- and given to the cells for 40 min in a humidified incubator at 37C with an atmo-
sphere of 95% air and 5% CO2.
Live-cell labeling and immunofluorescence
Live-cell labeling of surface GABAA receptors was performed in 21-25 DIV primary mouse hippocampal cultures. The neurons were
incubated with the primary antibodies against GABAAR g2 (1:500, #22403, Synaptic Systems) or anti-GABAAR a2 (1:500, #224104,
Synaptic Systems) diluted in NB medium containing 1%BSA for 10 min at 37C, 5%CO2 and 99% humidity. In experiments where
cyclosporine Awas used to inhibit calcineurin activity, or EGTA for Ca2+ chelation the cells were incubated with anti-GABAAR g2 anti-
body in NBmedium containing 1%BSA, 1 mMcyclosporine A or 2mMEGTA for 20min at 37C. Subsequently the cells were treated
with either the specific inhibitors or the respective controls (see Antibody and Peptide Treatment section) diluted in NB medium for
10min at 37C (in CaN activity experiments 1 mMcyclosporine A and for EGTA experiments 2mMwere additionally added). At the end
of the treatment the cells were fixed with 4% paraformaldehyde (PFA) in PB for 10-15 min at RT. Cells were then permeabilized with
0.3% Triton X-100 in PBS for 5 min and unspecific binding was blocked with 2% BSA in PBS for 30 min. For post hoc immunoflu-
orescence, the fixed neurons were incubated with anti-synapsin (1:1,000, #106006, Synaptic Systems), anti-gephyrin (1:500,
#147318, Synaptic Systems), anti-GABAAR g2 pSer327 (1:500, #ab73183, Abcam) or Myc-Tag (1:100, #PA1-981, ThermoFisher)
diluted in PBS containing 2% BSA for 1 h followed by an incubation with the following secondary antibodies (1:500, Jackson Lab-
oratories): anti-rabbit Cy2 (#111-225-144), anti-rabbit Cy3 (#111-165-144), anti-rabbit Cy5 (#711-175-152), anti-chicken Alexa
Fluor 488 (#703-545-155), anti-chicken Cy5 (#703-175-155), anti-guinea pig Cy3 (#706-166-148) diluted in PBS for 40 min. Finally,
the cells were incubated in a quenching solution containing 50 mM NH4Cl2 in PBS for 10 min and mounted with Fluoro-Gel (Electron
Miscroscopy Sciences) onto glass slides for imaging.
Widefield fluorescence imaging and analysis
2D images were acquired using an upright Axio Imager M2microscope (Zeiss) equipped with an oil-immersion objective (63x NA 1.4)
and a CCD camera. Primary dendrites of fluorescently labeled and isolated neurons were randomly chosen. Cells from a single cul-
ture preparation were imaged with the same sub-saturation exposure time. Background fluorescence of 2D images was determined
in ImageJ (National Institutes of Health) by placing ROIs on the dendrite of interest where no synaptic protein fluorescence was
visible. The mean gray value of all ROIs per dendrite was averaged and used as background in further analysis of this cell. Puncta
density and fluorescence intensity of synaptic proteins was detected in SynPAnal (Danielson and Lee, 2014) after subtraction of
2x background. In all cases the colocalization with synapsin-positive puncta was defined by overlap of at least 1 pixel after 2x back-
ground subtraction and was quantified in ImageJ. All analyses were performed by an experimenter blind to the treatment.
Single particle tracking and Fluo-4 imaging
GABAAR primary antibodies were tagged with quantum dots by mixing anti-GABAAR antibodies (1:10, #22403, Synaptic Systems),
F(ab’)2-goat anti-rabbit IgG Qdot655 (1:10, #Q11422MP, Thermo Fisher) and 10x casein solution (1:10, #SP-5020, Vector Labora-
tories) in PBS and vortexing for 10 min at RT. 10-14 DIV primary rat hippocampal neurons were incubated with a fluorescent (Oys-
ter-550) labeled anti-VGAT antibody (lumenal domain, 1:200, #131103C3, Synaptic Systems) in extracellular solution (145 mMNaCl,
10mMGlucose, 10mMHEPES, 5mMKCl, 2mMCaCl2, 2mMMgCl2) containing 0.5%BSA for 30min at 37
C followed by incubation
with the QD-GABAAR antibody mix (1:200) diluted in extracellular solution containing 0.5%BSA for 5 min at 37
C. Labeled cells were
washed in extracellular solution containing 0.5%BSAbefore imaging. Coverslips weremoved to a closed imaging chamber filledwith
extracellular solution at 37C. Recording was performed under an upright Olympus BX61 microscope equipped with a spinning disk
(Yokogava) and a 100x oil-immersion objective (NA 1.4), using the 561 nm laser line and appropriate emission filters to record consec-
utive images of synapse labeling and QD tagged GABAA-receptors. Images were captured by an EMCCD camera (iXon+ 897, Andor
Technology). The imaging systemwas controlled by the Andor iQ2 software. Image sequences of 1000 frames and acquisition rate of
33 Hz were recorded for QD labeled GABAARs and 100 frames (33 Hz) were acquired for VGAT labeled synapses. The QD-GABAAR
tracking was repeated every 5 min for up to 20 min.
The mean explored surface of QD-GABAARs was examined in ImageJ. Briefly, maximum projections of 1000 frames recordings
before and 10 min after control or Nogo-A neutralizing antibody application were generated. After background subtraction, the pro-
jections were binarized and the explored surface was quantified by the ‘‘Analyze Particles’’ function (0.1-Inf mm2, no circularity). The
data are then presented as explored average surface of QD-labeled GABAAR.e4 Cell Reports 29, 671–684.e1–e6, October 15, 2019
QD-GABAAR diffusion dynamics were analyzed using the PalmTracer plugin for MetaMorph software (Universal Imaging). In detail,
VGAT fluorescence was averaged over 100 frames, background fluorescence was subtracted and VGAT positive areas weremarked
as synaptic compartments. Throughout the text and figures, all data marked with ‘‘synaptic’’ correspond to QD-labeled GABAAR
found in VGAT labeled spots. Localization of QDs was carried out using a wavelet-based algorithm. Trajectories of QD-tagged
GABAARs were reconstructed by a simulated annealing algorithm (Izeddin et al., 2012). The diffusion coefficient (D), defined as
a measure for the random motion of GABAAR within the cellular membrane based on the surface they explored over time was
generated by a linear fit of the first 4 points of the mean square displacement (MSD) over time using MSD(t) = < r2 > (t) = 4Dt.
Trajectories shorter than 8 points were not include into the analysis. The blinking of QDs was not taken into account for the recon-
struction of trajectories, all shorter trajectories were rejected and not further analyzed. For MSD plots we averaged the MSDs gener-
ated from trajectories withR 34 points (1 s, Figure S2). The confinement area of GABAARs in the membrane was calculated by fitting
the MSD according to the procedure described by Kusumi et al. (1993).
In experiments where QD-SPT was paired with Ca2+ imaging, neurons were incubated with Fluo-4 AM (0.5 mM, #F14201, Fisher
Scientific) together with the antibody coated QD-anti-GABAAR g2 in extracellular solution containing 0.5% BSA for 5 min at 37
C.
Fluo-4 fluorescence was imaged within the dendrites of the labeled cells in sequences of 1000 frames at 33 Hz every 5 min for up
to 20 min. Fluo-4 fluorescence analysis was performed in ImageJ (National Institutes of Health) by averaging fluorescence intensity
over 1000 frames after background subtraction. The ratio of fluorescence intensities (F/F0), where F is a fluorescence intensity and F0
is the intensity at the first time point, was assessed by normalization to the first time point of each experiment. Statistical analysis was
performed in Prism (GraphPad7) using a Two-Way repeated-measures ANOVA followed by a Bonferroni post-test. Correlation be-
tween diffusion dynamics and Fluo-4 intensity of single cells was tested using a Spearman test. All analyses were performed by an
experimenter blind to the treatment.
Ca2+-imaging
Primary mouse hippocampal neurons were transfected with GCaMP5g expression plasmid using Lipofectamine 2000 (Invitrogen) at
DIV20-25. One day after lipofection coverslips were moved to a recording chamber filled with Hank’s buffered salt solution (HBSS)
and let rest for 30 min at RT. Imaging of randomly chosen GCaMP5g expressing neurons was performed using a 40x objective
(LUMPLFLN W, NA 0.7) with an Olympus fluorescence Microscope BX61WI, equipped with a CCD camera. Time lapse recordings
of 500 frames at 5 Hz were acquired using XCellence pro imaging software. The coverslips with the transfected cells were incubated
in a recording chamber filled with HBSS for 30 min to adjust. A continuous flow of the HBSS solution was achieved using a peristaltic
pump and kept at a constant speed of 1 mL/min. The neurons were treated with the antibodies and peptides (Figures 5A–5C, see
Antibody and Peptide Treatment section) diluted in HBSS at RT. For treating the cells with the different antibodies another HBSS
solution was prepared separately with a final concentration of 5 mg/ml. The cells were imaged twice before and four times after start-
ing the treatment at an interval of ten minutes.
Analysis of the data was performed using ImageJ software. The region of interest (ROI) used in the image analysis was chosen to
correspond to dendritic spines or the cell body. For the whole duration of the treatment always the same spines were observed. An
additional ROI was drawn for background correction. To calculate the change in fluorescence intensity the following equation was
used: DF/F0 = [(F-B)-(F0-B0)] / (F0-B0), where F0 and B0 represent the mean gray value of the selected ROIs at resting conditions. The
amplitude and frequency of the transients were averaged for each spine of one cell. Data were normalized to the first recording before
wash-in of the antibodies and peptides. For statistical analysis a repeated-measures ANOVA was performed. To test whether the
assumption of sphericity is violated within the treatments, the Mauchly’s test was done, followed by a Greenhouse-Geisser correc-
tion if sphericity has been violated. Further a paired Student’s t test was used to test for significances between the different treat-
ments. All analyses were performed by an experimenter blind to the treatment.
Synaptosome isolation
The synaptosome isolation procedure was adapted from Suresh and Dunaevsky, (2015). Briefly, acute hippocampal slices were
treated with control antibody, Nogo-A neutralizing antibody (5 mg/ml) or KCl (55 mM) in carbogenated ACSF at RT for 10 min and
subsequently transferred to a medium containing 0.32 M sucrose, 5 mM HEPES (pH 7.5), 0.1 mM EDTA (pH 8.0) and Complete pro-
tease inhibitor cocktail pellet (Roche, 1 tablet per 50 mL). The slices were homogenized with a hand held homogenizer (DWK Life
Sciences) on ice for 1 min. After centrifugation at 1,500 rpm at 4C for 10 min the supernatant containing suspended synaptosomes
was spun down at 13,500 rpm at 4C for 20min. The synaptosomeswere lysed in RIPA buffer containing (50mMTRIS, 150mMNaCl,
2 mM EGTA, 1% Triton X-100, 0.25% DOC, pH7.5) on a rotor at 4C for 30 min. Protein concentration was assessed by Bradford
assay.
Western blot analysis
Protein samples were prepared for western blot analysis by adding SDS and b-mercaptoethanol. 20 mg of proteins were loaded and
separated on 4%–12%polyacrylamide gradient gels followed by blotting onto nitrocellulosemembranes using a semidry or tank blot.
The membranes were blocked with 5% milk in TBS-Tween for 1 h at room temperature and incubated at 4C overnight with theCell Reports 29, 671–684.e1–e6, October 15, 2019 e5
following primary antibodies diluted in TBS-Tween: anti-GluR1 (1:1,000, #AB1504, Merck Millipore), anti-Nogo-A (5 mg/ml, 11C7, gift
from Martin Schwab, ETH Zurich), anti-GAPDH (1:15,000, #G9545, Sigma-Aldrich). The membrane was washed in TBS-Tween and
incubated for 1 h at room temperature with the anti-mouse (1:20,000, #A9044, Sigma-Aldrich), anti-rabbit (1:20,000, #A0545, Sigma-
Aldrich) or anti-goat (1:20,000, #305-035-003, Jackson Laboratories) secondary antibodies conjugated with HRP. Immunoreactivity
was detected on an X-ray film by chemoluminescence (Luminata Crescendo Western HRP substrate, Millipore) and densitometry of
bands was conducted in EasyWin32. A Student’s t test was used to assess differences between treatments.
DATA AND CODE AVAILABILITY
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